LIFNano Therapeutics company

LIFNano Therapeutics was founded in 2013 as a spin-out from the University of Cambridge, progressing to a clinical stage Nano-Bio-Med company specifically focused on targeted delivery of the biologic, Leukaemia Inhibitory Factor (LIF).
Technology: P4 Medicine
Industry: Preventive Medicine
Headquarters: Cambridge, Cambridgeshire, United Kingdom
Founded Date: 2015
Employees Number: 1-10
Funding Status: N/A
Investors Number: 2
Total Funding: £1M
Estimated Revenue: Less than $1M
Last Funding Type: Grant

Visit Website
info@lifnano.com
@LIFNanoRx
Register and Claim Ownership